BMS 986178
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for BMS 986178, covering 2022-01-25 to 2024-12-11. Get the full timeline:
Most recent: Clinical Trial Update: TLR9 Agonist SD-101, Anti-OX40 Antibody BMS 986178, and Radiation Therapy in Treating Patients With Low-Grade B-Cell Non-Hodgkin Lymphomas [Phase 1]